Subramanian Venkateswaran, Moorleghen Jessica J, Balakrishnan Anju, Howatt Deborah A, Chishti Athar H, Uchida Haruhito A
Saha Cardiovascular Research Center, University of Kentucky, Lexington, Kentucky, United States of America.
PLoS One. 2013 Aug 19;8(8):e72214. doi: 10.1371/journal.pone.0072214. eCollection 2013.
Recently, we demonstrated that angiotensin II (AngII)-infusion profoundly increased both aortic protein and activity of calpains, calcium-activated cysteine proteases, in mice. In addition, pharmacological inhibition of calpain attenuated AngII-induced abdominal aortic aneurysm (AA) in mice. Recent studies have shown that AngII infusion into mice leads to aneurysmal formation localized to the ascending aorta. However, the precise functional contribution of calpain isoforms (-1 or -2) in AngII-induced abdominal AA formation is not known. Similarly, a functional role of calpain in AngII-induced ascending AA remains to be defined. Using BDA-410, an inhibitor of calpains, and calpain-1 genetic deficient mice, we examined the relative contribution of calpain isoforms in AngII-induced ascending and abdominal AA development.
METHODOLOGY/RESULTS: To investigate the relative contribution of calpain-1 and -2 in development of AngII-induced AAs, male LDLr -/- mice that were either calpain-1 +/+ or -/- were fed a saturated fat-enriched diet and infused with AngII (1,000 ng/kg/min) for 4 weeks. Calpain-1 deficiency had no significant effect on body weight or blood pressure during AngII infusion. Moreover, calpain-1 deficiency showed no discernible effects on AngII-induced ascending and abdominal AAs. Interestingly, AngII infusion induced increased expression of calpain-2 protein, thus compensating for total calpain activity in aortas of calpain-1 deficient mice. Oral administration of BDA-410, a calpain inhibitor, along with AngII-infusion significantly attenuated AngII-induced ascending and abdominal AA formation in both calpain-1 +/+ and -/- mice as compared to vehicle administered mice. Furthermore, BDA-410 administration attenuated AngII-induced aortic medial hypertrophy and macrophage accumulation. Western blot and immunostaining analyses revealed BDA-410 administration attenuated AngII-induced C-terminal fragmentation of filamin A, an actin binding cytoskeletal protein in aorta.
Calpain-2 compensates for loss of calpain-1, and both calpain isoforms are involved in AngII-induced aortic aneurysm formation in mice.
最近,我们证明了在小鼠中输注血管紧张素II(AngII)可显著增加主动脉中钙蛋白酶(钙激活的半胱氨酸蛋白酶)的蛋白水平和活性。此外,对钙蛋白酶的药理学抑制可减轻小鼠中AngII诱导的腹主动脉瘤(AA)。最近的研究表明,向小鼠输注AngII会导致升主动脉局部形成动脉瘤。然而,钙蛋白酶同工型(-1或-2)在AngII诱导的腹主动脉瘤形成中的确切功能作用尚不清楚。同样,钙蛋白酶在AngII诱导的升主动脉瘤中的功能作用仍有待确定。使用钙蛋白酶抑制剂BDA-410和钙蛋白酶-1基因缺陷小鼠,我们研究了钙蛋白酶同工型在AngII诱导的升主动脉瘤和腹主动脉瘤发展中的相对作用。
方法/结果:为了研究钙蛋白酶-1和-2在AngII诱导的主动脉瘤发展中的相对作用,将钙蛋白酶-1 +/+或-/-的雄性LDLr -/-小鼠喂食富含饱和脂肪的饮食,并输注AngII(1000 ng/kg/分钟)4周。在输注AngII期间,钙蛋白酶-1缺陷对体重或血压没有显著影响。此外,钙蛋白酶-1缺陷对AngII诱导的升主动脉瘤和腹主动脉瘤没有明显影响。有趣的是,输注AngII可诱导钙蛋白酶-2蛋白表达增加,从而补偿钙蛋白酶-1缺陷小鼠主动脉中的总钙蛋白酶活性。与给予赋形剂的小鼠相比,口服钙蛋白酶抑制剂BDA-410并同时输注AngII可显著减轻AngII诱导的钙蛋白酶-1 +/+和-/-小鼠的升主动脉瘤和腹主动脉瘤形成。此外,给予BDA-410可减轻AngII诱导的主动脉中膜肥厚和巨噬细胞积聚。蛋白质印迹和免疫染色分析显示,给予BDA-410可减轻AngII诱导的丝状肌动蛋白A(一种主动脉中与肌动蛋白结合的细胞骨架蛋白)的C末端片段化。
钙蛋白酶-2可补偿钙蛋白酶-1的缺失,并且两种钙蛋白酶同工型均参与小鼠中AngII诱导的主动脉瘤形成。